title: Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence population.
abstract: Interpretation of human immunodeficiency virus (HIV) antibody results that are "indeterminate" rather than clearly positive or negative is problematic for the person delivering the result as well as for the individual being tested. To improve counseling messages for these individuals, we evaluated data collected from a well-characterized cohort of 387 blood donors who had been monitored for up to 2 years. We sought to determine if persons with indeterminate Western blot patterns were infected with HIV, and whether information derived from follow-up monitoring would assist in the development of counseling messages for persons on whom no follow-up information was available. Donors were studied by laboratory assays, clinical evaluation, and assessment of risk for HIV. The absence of HIV infection in 97 of 98 donors with indeterminate Western blot patterns was confirmed by clinical follow-up, Western blot assays of sequential samples, and negative gene amplification results. We propose supplemental guidelines to be used as an adjunct to existing interpretive criteria for counseling individuals when they first present with an indeterminate Western blot finding.
authors.affiliation: American Red Cross Blood Services, Syracuse, NY 13202.
authors.forename: N L
authors.initials: NL
authors.lastname: Dock
authors.forename: S H
authors.initials: SH
authors.lastname: Kleinman
authors.forename: M A
authors.initials: MA
authors.lastname: Rayfield
authors.forename: C A
authors.initials: CA
authors.lastname: Schable
authors.forename: A E
authors.initials: AE
authors.lastname: Williams
authors.forename: R Y
authors.initials: RY
authors.lastname: Dodd
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000453:epidemiology*; D001782:Blood Donors; D015153:Blotting, Western; D015331:Cohort Studies; D003376:Counseling; D005500:Follow-Up Studies; D006679:HIV Seropositivity; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D007124:Immunoenzyme Techniques; D015995:Prevalence; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors